Skip to content

Novel approaches in in-vitro fertilisation (IVF)

Novel approaches in in-vitro fertilisation (IVF)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN35766970
Enrollment
400
Registered
2006-03-08
Start date
2002-02-01
Completion date
Unknown
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility Pregnancy and Childbirth Infertility

Interventions

Patients were randomly assigned to undergo either: 1. Mild treatment (mild ovarian stimulation with gonadotropin-releasing hormone [GnRH] antagonist co-treatment combined with single e

Sponsors

University Medical Centre Utrecht (UMCU) (The Netherlands)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Patients with an indication for IVF or IVF/intracytoplasmic sperm injection (ICSI) based on tubal, male or unexplained infertility were recruited 2. Patients less than 38 years with a normal menstrual cycle (cycle length between period 25 - 35 days) and without severe obesity or underweight (body mass index [BMI] 18 - 28 kg/m^2) were eligible for the study

Exclusion criteria

Exclusion criteria: Does not comply with the above inclusion criteria.

Design outcomes

Primary

MeasureTime frame
The primary outcome parameters chosen for this study were: 1. Pregnancy within one year of treatment after randomisation leading to term (greater than 37 weeks gestation) live birth 2. Total costs per couple and child up to six weeks after expected delivery 3. Patient discomfort/distress during IVF treatment

Secondary

MeasureTime frame
No secondary outcome measures

Countries

Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 7, 2026